Open, randomized, multi-center phase II study comparing efficacy and tolerability of Erlotinib vs. Carboplatin/Vinorelbin in elderly patients (>70 years of age) with untreated non-small cell lung cancer
Heigener, D.F, Deppermann, K.M, Pawel, J.v, Fischer, J.R, Kortsik, C, Bohnet, S, Eiff, M.v, Koester, W, Thomas, M, Schnabel, P.A, Reck, M
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2014)
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2014)
Get full text
Journal Article